Form 13-F position report

BIO-RAD LABS CL A

Reported by Allspring Global Investments Holdings LLC

BIO CUSIP 090572207 Manager CIK 0001890906

Reported 156,413 shares, down 7,370 (4.5%) from the prior quarter.

Reported value -24.6%; share count -4.5% vs. the prior quarter.

Reduced
% of reported 13F value 0.07% This manager · Q2 2024
Shares 156,413 Quarter-end amount reported
Reported value $42,717,986 Fair value at quarter end
Consecutive quarters held 11 Through Q2 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 194218000
2022-03-31 159725000
2022-06-30 114802000
2022-09-30 111252000
2022-12-31 114367811
2023-03-31 124163058
2023-06-30 89057111
2023-09-30 53332340
2023-12-31 53640746
2024-03-31 56647667
2024-06-30 42717986
2024-09-30 49759406
2024-12-31 46881259
2025-03-31 32627280
2025-06-30 32363935
2025-09-30 40153827
2025-12-31 39444242
2026-03-31 23929217
2026-06-30 20676870
2026-09-30 7878365

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for BIO-RAD LABS CL A held by Allspring Global Investments Holdings LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 22,157 -47,441 (-68.2%) 0.01% $7,878,365 2026-11-04
Q2 2026 Reduced 69,598 -16,367 (-19.0%) 0.03% $20,676,870 2026-08-13
Q1 2026 Reduced 85,965 -43,246 (-33.5%) 0.04% $23,929,217 2026-05-05
Q4 2025 Reduced 129,211 -5,556 (-4.1%) 0.06% $39,444,242 2026-01-15
Q3 2025 Added 134,767 +4,262 (3.3%) 0.06% $40,153,827 2025-10-20
Q2 2025 Reduced 130,505 -5,442 (-4.0%) 0.05% $32,363,935 2025-07-25
Q1 2025 Reduced 135,947 -7,790 (-5.4%) 0.06% $32,627,280 2025-04-24
Q4 2024 Reduced 143,737 -4,985 (-3.4%) 0.08% $46,881,259 2025-01-29
Q3 2024 Reduced 148,722 -7,691 (-4.9%) 0.08% $49,759,406 2024-10-18
Q2 2024 Reduced 156,413 -7,370 (-4.5%) 0.07% $42,717,986 2024-07-26
Q1 2024 Reduced 163,783 -2,344 (-1.4%) 0.09% $56,647,667 2024-04-18
Q4 2023 Added 166,127 +17,341 (11.7%) 0.09% $53,640,746 2024-01-25
Q3 2023 Reduced 148,786 -86,117 (-36.7%) 0.09% $53,332,340 2023-10-27
Q2 2023 Reduced 234,903 -24,299 (-9.4%) 0.14% $89,057,111 2023-07-18
Q1 2023 Reduced 259,202 -12,785 (-4.7%) 0.21% $124,163,058 2023-04-13
Q4 2022 Added 271,987 +5,282 (2.0%) 0.2% $114,367,811 2023-01-23
Q3 2022 Added 266,705 +34,780 (15.0%) 0.2% $111,252,000 2022-10-26
Q2 2022 Reduced 231,925 -51,665 (-18.2%) 0.19% $114,802,000 2022-07-25
Q1 2022 Added 283,590 +26,539 (10.3%) 0.2% $159,725,000 2022-04-27
Q4 2021 New 257,051 +257,051 (0.0%) 0.22% $194,218,000 2022-01-28

Who else reported the position

519 managers reported BIO-RAD LABS CL A for Q2 2024.

Managers reporting BIO-RAD LABS CL A in Q2 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Reduced 2,374,507 -46,827 0.01% $648,501,607 45 qtrs
BlackRock Inc Added 1,550,569 +70,665 < 0.01% $423,475,820 45 qtrs
Veritas Asset Management LLP Reduced 1,128,811 -18,286 2.33% $308,289,572 9 qtrs
STATE STREET CORPORATION Reduced 859,891 -13,784 0.01% $234,844,831 35 qtrs
VAN ECK ASSOCIATES CORP New 659,222 +659,222 0.26% $180,040,000 1 qtr
Select Equity Group L P Added 649,522 +134,856 0.7% $177,390,953 5 qtrs
First Eagle Investment Management LLC Added 636,275 +634,311 0.39% $173,773,065 5 qtrs
EARNEST PARTNERS LLC Added 606,788 +91,882 0.77% $165,719,871 43 qtrs
Invesco Ltd Added 548,048 +87,042 0.03% $149,677,389 45 qtrs
DIMENSIONAL FUND ADVISORS LP Added 494,604 +193,700 0.04% $135,081,112 45 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2024
Filed
July 26, 2024
Filing type
13F-HR
Position type
CL A

Voting authority reported

Sole
25,417
Shared
0
None
130,996

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.